Apply to Join

Emergency Response to the Ebola Outbreak in DRC

by International Medical Corps
Emergency Response to the Ebola Outbreak in DRC
Emergency Response to the Ebola Outbreak in DRC
Emergency Response to the Ebola Outbreak in DRC
Emergency Response to the Ebola Outbreak in DRC
Mar 19, 2020

Using Research to Replicate Success

Dr. Adam Levine leads the research in May 2019.
Dr. Adam Levine leads the research in May 2019.

Throughout the West African Ebola outbreak from 2014 to 2015, the 2018 outbreak in Northwestern Democratic Republic of the Congo (DRC) and the current, second-largest outbreak in history in Northeastern DRC, International Medical Corps was there – gathering data to identify successes and extract lessons learned even as we provided care and technical training. As a result, the International Medical Corps’ Ebola Research Team has assembled one of the world’s largest — if not the largest — archive of published research on the Ebola virus and its treatment.

Two recent studies highlight the importance of collecting information to record lessons learned for the benefit of future responses: 1) the Pamoja Tulinde Maisha (PALM), or Together Save Lives, trial, which studied the effectiveness of four drugs to treat the Ebola virus; and 2) a study on prophylactic antibiotics, or the use of the antibiotics to prevent secondary infections.

With support from national, international, intergovernmental, such as the WHO, and other humanitarian organizations during the PALM trial, International Medical Corps helped test the effectiveness of four drugs in treating Ebola among more than 680 patients. After a string of disappointments in the quest for useful treatments, the results demonstrated that two of the four drugs dramatically increase patients’ chances of survival.

In the 2019 Science magazine, Kai Kupferschmidt writes, “the results [of the PALM study] should help combat the disease not only by improving patients’ chances of survival, but also by encouraging people to seek treatment early. With no effective drugs available, people with symptoms have often tried to evade detection and sought out traditional healers, which has fueled outbreaks.”

Misinformation can make the spread of diseases, such as the Ebola virus, more likely and also encourage people to be more resistant to treatment. However, results of studies like these, ones that demonstrate fewer lives lost and more effective treatments, may help convince people to seek care if they believe there is hope. 

The second study, using data gathered during the West African Ebola outbreak from 2014 to 2015, involved 360 patients diagnosed with the virus. The results found that the mortality rate among patients given the antibiotic fell to just more than half—54.7%, compared to a death rate of more than 73% among those who did not receive the drug. Our study constitutes the first evidence-based research to support the well-known practice. Evidence-based research is important because it helps transform subjective knowledge into objective data, informing not just our future responses, but also those of humanitarian agencies worldwide.

Today, our teams are again collecting data to identify the successes of our work in northeastern DRC and learn as many lessons as we can before the next emergency. Research and knowledge enhance the value of our work – and, most importantly, save lives.

We thank the GlobalGiving community of donors for supporting our efforts to inform and prevent future outbreaks.

Citations

 “Independent Monitoring Board Recommends Early Termination of Ebola Therapeutics Trial in DRC Because of Favorable Results with Two of Four Candidates.” National Institute of Allergy and Infectious Diseases, 12 Aug. 2019, Retrieved on 12 March 2020, from: www.niaid.nih.gov/news-events/independent-monitoring-board-recommends-early-termination-ebola-therapeutics-trial-drc

K. Kupferschmidt, Successful Ebola treatments promise to tame outbreaksScience, Vol. 365, p. 628, 16 August 2019, Retrieved on 12 March 2020, from: https://science.sciencemag.org/content/365/6454/628

Tyler Marshall, International Medical Corps Study Offers First Evidence That a Low-Cost Antibiotic Can Reduce Deaths in Ebola Patients, International Medical Corps, 10 February 2020, retrieved on 12 March 2020, from:https://internationalmedicalcorps.org/story/international-medical-corps-study-offers-first-evidence-that-a-low-cost-antibiotic-can-reduce-deaths-in-ebola-patients/

Ebola survivors leaving the treatment facility.
Ebola survivors leaving the treatment facility.
Share on Twitter Share on Facebook
Comments:

About Project Reports

Project Reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you will get an e-mail when this project posts a report. You can also subscribe for reports via e-mail without donating.

Get Reports via Email

We'll only email you new reports and updates about this project.

Organization Information

International Medical Corps

Location: Los Angeles, CA - USA
Website:
Project Leader:
Kelli Maddock
Los Angeles, CA United States
$3,511 raised of $15,000 goal
 
38 donations
$11,489 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

International Medical Corps has earned this recognition on GlobalGiving:
Add Project to Favorites

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Sign up for the GlobalGiving Newsletter

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.